Basis: Trailing twelve months (TTM), to the latest fiscal quarter end. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on invested capital (ROIC) high or low?
The return on invested capital (ROIC) of -101.30% is 59% below its 5-year average of -63.61%, near the high end of its 5-year range (-358.13%–-28.96%).
As of the fiscal period ended Tuesday, June 30, 2026. 36.26% below its 12-month average of -74.34%.
Trailing-twelve-month return on invested capital at each fiscal quarter end; no daily interpolation. Q2 FY2026 (2026-06-30): -101.30%.
RETURN ON INVESTED CAPITAL (ROIC)
-101.30%
RETURN ON INVESTED CAPITAL (ROIC) AVG TTM
-74.34%
RETURN ON INVESTED CAPITAL (ROIC) AVG 3Y
-61.19%
RETURN ON INVESTED CAPITAL (ROIC) AVG 5Y
-63.61%
RETURN ON INVESTED CAPITAL (ROIC) AVG 10Y
-100.56%
RETURN ON INVESTED CAPITAL (ROIC) AVG 15Y
N/A
RETURN ON INVESTED CAPITAL (ROIC) AVG 20Y
N/A
CURRENT VS TTM AVG
-36.26%
CURRENT VS 3Y AVG
-65.55%
CURRENT VS 5Y AVG
-59.24%
CURRENT VS 10Y AVG
-0.74%
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-33.39%
median of 720 covered companies
CURRENT VS SECTOR MEDIAN
-203.43%
vs the sector median at left
Corbus Pharmaceuticals Holdings, Inc.
Market Cap
$107.28M
Return on Invested Capital (ROIC)
-101.30%
TTM Avg
-74.34%
3Y Avg
-61.19%
5Y Avg
-63.61%
Market Cap
$108.30M
Return on Invested Capital (ROIC)
-47.54%
TTM Avg
-30.79%
3Y Avg
-47.42%
5Y Avg
-44.72%
Market Cap
$109.36M
Return on Invested Capital (ROIC)
-352.19%
TTM Avg
-1462.52%
3Y Avg
-874.13%
5Y Avg
-711.22%
Market Cap
$109.38M
Return on Invested Capital (ROIC)
-92.16%
TTM Avg
-430.04%
3Y Avg
-259.02%
5Y Avg
-188.28%
Market Cap
$107.43M
Return on Invested Capital (ROIC)
-34.77%
TTM Avg
-10.04%
3Y Avg
-11.68%
5Y Avg
-11.21%
Market Cap
$109.46M
Return on Invested Capital (ROIC)
-223.06%
TTM Avg
-221.51%
3Y Avg
-125.15%
5Y Avg
-99.68%
Market Cap
$105.01M
Return on Invested Capital (ROIC)
41.64%
TTM Avg
-39.48%
3Y Avg
-25.23%
5Y Avg
-17.21%
Market Cap
$103.68M
Return on Invested Capital (ROIC)
-47.75%
TTM Avg
-127.40%
3Y Avg
-174.63%
5Y Avg
-174.63%
Market Cap
$109.07M
Return on Invested Capital (ROIC)
-6.84%
TTM Avg
-23.14%
3Y Avg
-32.81%
5Y Avg
-31.36%
| NAME | MARKET CAP | RETURN ON INVESTED CAPITAL (ROIC) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Corbus Pharmaceuticals Holdings, Inc. (CRBP) | $107.28M | -101.30% | -74.34% | -61.19% | -63.61% |
| Black Diamond Therapeutics, Inc. (BDTX)vs › | $108.30M | -47.54% | -30.79% | -47.42% | -44.72% |
| Outlook Therapeutics, Inc. (OTLK)vs › | $109.36M | -352.19% | -1462.52% | -874.13% | -711.22% |
| Immunic, Inc. (IMUX)vs › | $109.38M | -92.16% | -430.04% | -259.02% | -188.28% |
| Cumberland Pharmaceuticals Inc. (CPIX)vs › | $107.43M | -34.77% | -10.04% | -11.68% | -11.21% |
| Insight Molecular Diagnostics Inc. (IMDX)vs › | $109.46M | -223.06% | -221.51% | -125.15% | -99.68% |
| Definitive Healthcare Corp. (DH)vs › | $105.01M | 41.64% | -39.48% | -25.23% | -17.21% |
| Polaryx Therapeutics, Inc. Common Stock (PLYX)vs › | $103.68M | -47.75% | -127.40% | -174.63% | -174.63% |
| Apyx Medical Corporation (APYX)vs › | $109.07M | -6.84% | -23.14% | -32.81% | -31.36% |
| Aardvark Therapeutics, Inc. Common Stock (AARD)vs › | $109.86M | -97.99% | -45.11% | -60.38% | -60.38% |
ROIC
-101.3%
ROE
-99.7%
ROIC = NOPAT / Invested Capital, where NOPAT = Operating Income × (1 − effective tax rate) and Invested Capital = Total Assets − (Current Liabilities − Short-Term Debt)
Return on invested capital measures the after-tax operating return a company earns on the capital invested in the business. TGMCharts computes it from reported statements: trailing-twelve-month operating income after tax, over invested capital at the latest balance sheet — total assets less the non-interest-bearing current liabilities (payables, accruals, deferred revenue) that fund them; short-term debt stays in the capital base. The tax rate is the period's own effective rate (income tax ÷ pretax income), capped at 45%; when pretax income is zero or negative, or the tax line is a net benefit, no tax is deducted — the operating figure is shown untaxed rather than adjusted by an assumed rate. Not shown for banks, insurers or funds.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON INVESTED CAPITAL (ROIC) |
|---|---|
| 2026-06-30 | -101.30% |
| 2026-03-31 | -70.44% |
| 2025-12-31 | -57.84% |
| 2025-09-30 | -82.15% |
| 2025-06-30 | -59.99% |
| 2025-03-31 | -45.88% |
| 2024-12-31 | -33.82% |
| 2024-09-30 | -30.30% |
| 2024-06-30 | -28.96% |
| 2024-03-31 | -33.17% |
| 2023-12-31 | -358.13% |
| 2023-09-30 | -202.61% |
| 2023-06-30 | -129.24% |
| 2023-03-31 | -102.63% |
| 2022-12-31 | -61.31% |
| 2022-09-30 | -51.38% |
| 2022-06-30 | -53.67% |
| 2022-03-31 | -56.97% |
| 2021-12-31 | -59.20% |
| 2021-09-30 | -65.22% |
| 2021-06-30 | -85.22% |
| 2021-03-31 | -92.64% |
| 2020-12-31 | -172.71% |
| 2020-09-30 | -237.32% |
| 2020-06-30 | -214.34% |
| 2020-03-31 | -259.71% |
| 2019-12-31 | -513.78% |
| 2019-09-30 | -179.63% |
| 2019-06-30 | -104.02% |
| 2019-03-31 | -143.96% |
| 2018-12-31 | -193.72% |
| 2018-09-30 | -113.03% |
| 2018-06-30 | -73.92% |
| 2018-03-31 | -55.13% |
| 2017-12-31 | -55.09% |
| 2017-09-30 | -91.24% |
| 2017-06-30 | -73.37% |
| 2017-03-31 | -56.04% |
| 2016-12-31 | -215.79% |
| 2016-09-30 | -111.88% |
| 2016-06-30 | -66.89% |
| 2016-03-31 | -156.72% |
| 2015-12-31 | -94.12% |
| 2015-09-30 | -66.43% |
| 2015-06-30 | -85.48% |
| 2015-03-31 | -85.57% |
| 2014-12-31 | -44.07% |
| 2014-09-30 | -23.47% |
| 2014-06-30 | -11.02% |
